MEDICA - Establishing and Building Clinical Evidence in the Early Stages of a Medical Technology
acroMIS does 10% Consulting and 90% Actual Commercial Implementation in Asia, Europe and America Using a Cost-Efficient Process.
Encinitas, CA, November 21, 2011 --(PR.com)-- MEDICA, the premiere global Life Sciences/Medical trade show took place in Düsseldorf, Germany from November 16 to 19, 2011. A high percentage of MEDICA visitors came from overseas markets such as Asia, Australia, North Africa, Latin America and, increasingly, from Arab countries. MEDICA visitors who attend the show are professionals there to make significant buying decisions.
“MEDICA is the best single event to meet potential distribution partners from international markets outside the U.S.,” says Haio Fauser, principal consultant at acroMIS implementation and development (a.i.d.). “For our U.S. clients, acroMIS uses MEDICA as an opportunity to network within the medical device industry and to look at alternative markets for achieving clinical and commercial milestones.”
Establishing and building clinical evidence in the early stages of a medical technology company is vital to the rapid success in today’s changing regulatory and economic environment. acroMIS is the right partner for evidence building in Europe, Asia and America; Europe, the USA and Japan account for 89% of the world market for medical devices and acroMIS consultants have in-depth implementation experience in those markets. With our solutions we focus on three areas of evidence building:
Key Opinion Leader Connections,
Proof-of-concept Lab Trials,
First-in-man Clinical Trials.
Haio Fauser is the co-founder and principal consultant of acroMIS. Haio has comprehensive knowledge of the clinical development process, and he led numerous project teams of preclinical and clinical stage programs from concept to first-in-man uses. He speaks English, German, Japanese and French. He can be reached at +1 (650) 336-8641 (voicemail) or info@acroMIS.com (email) for more details about how acroMIS can assist your company.
###
“MEDICA is the best single event to meet potential distribution partners from international markets outside the U.S.,” says Haio Fauser, principal consultant at acroMIS implementation and development (a.i.d.). “For our U.S. clients, acroMIS uses MEDICA as an opportunity to network within the medical device industry and to look at alternative markets for achieving clinical and commercial milestones.”
Establishing and building clinical evidence in the early stages of a medical technology company is vital to the rapid success in today’s changing regulatory and economic environment. acroMIS is the right partner for evidence building in Europe, Asia and America; Europe, the USA and Japan account for 89% of the world market for medical devices and acroMIS consultants have in-depth implementation experience in those markets. With our solutions we focus on three areas of evidence building:
Key Opinion Leader Connections,
Proof-of-concept Lab Trials,
First-in-man Clinical Trials.
Haio Fauser is the co-founder and principal consultant of acroMIS. Haio has comprehensive knowledge of the clinical development process, and he led numerous project teams of preclinical and clinical stage programs from concept to first-in-man uses. He speaks English, German, Japanese and French. He can be reached at +1 (650) 336-8641 (voicemail) or info@acroMIS.com (email) for more details about how acroMIS can assist your company.
###
Contact
acroMIS Implementation And Development
Haio Fauser
(650) 336-8641
implementation.acromis.com
Haio Fauser
(650) 336-8641
implementation.acromis.com
Contact
Categories